SMMT Summit Therapeutics PLC ADRs

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:SUMM.

$5.39  -0.09 (-1.64%)
As of 04/13/2021 15:59:44 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  03/04/2015
Outstanding shares:  82,916,189
Average volume:  134,326
Market cap:   $454,380,716
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    86627T108
ISIN:        US86627T1088
Sedol:      BMTVQS7
Valuation   (See tab for details)
PE ratio:   -8.84
PB ratio:   5.70
PS ratio:   458.08
Return on equity:   -66.18%
Net income %:   -5,300.84%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy